Who owns Oramed Pharm?

Tip: Access positions for across all investors

Analyze quarterly positions in Oramed Pharm with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Oramed Pharm stock

Who bought or sold Oramed Pharm this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BML Capital Management 2.2M $5.3M 62% Sep 2024
 View chart
Murchinson 1.7M $4.4M 23% Jun 2024
 View chart
Rathbones Brothers 290k $745k 0% Jun 2024
 View chart
Two Sigma Advisers 259k $666k -2% Jun 2024
 View chart
Renaissance Technologies 245k $599k 6% Sep 2024
 View chart
Bank of America Corporation 172k $420k -1% Sep 2024
 View chart
Two Sigma Investments 150k $386k 12% Jun 2024
 View chart
Susquehanna International 134k $328k 7% Sep 2024
 View chart
Connor, Clark & Lunn Investment Management 112k $272k 100% Sep 2024
 View chart
BlackRock 92k $225k 100% Sep 2024
 View chart
BlackRock 90k $231k 0% Jun 2024
 View chart
Squarepoint Ops 82k $210k -8% Jun 2024
 View chart
State Street Corporation 59k $152k 2% Jun 2024
 View chart
Jane Street 58k $142k 4% Sep 2024
 View chart
Dimensional Fund Advisors 49k $119k 55% Sep 2024
 View chart
Morgan Stanley 45k $117k 2% Jun 2024
 View chart
LPL Financial 39k $94k -4% Sep 2024
 View chart
Citadel Advisors 28k $67k 100% Sep 2024
 View chart
Pnc Financial Services 26k $64k 0% Sep 2024
 View chart
Geode Capital Management 26k $62k 0% Sep 2024
 View chart
Wells Fargo & Company 25k $61k -2% Sep 2024
 View chart
Marshall Wace 23k $55k 100% Sep 2024
 View chart
American Century Companies 20k $48k 0% Sep 2024
 View chart
Savvy Advisors 19k $46k 0% Sep 2024
 View chart
Atria Investments 18k $44k 8% Sep 2024
 View chart
Sage Capital Management 17k $41k 0% Sep 2024
 View chart
Virtu Financial 15k $38k -36% Jun 2024
 View chart
Barclays 13k $32k 0% Sep 2024
 View chart
Assenagon Asset Management 13k $32k -20% Sep 2024
 View chart
Tower Research Capital 12k $32k 365% Jun 2024
 View chart
N.E.W. Advisory Services 12k $30k 0% Sep 2024
 View chart
Journey Strategic Wealth 12k $30k 12% Sep 2024
 View chart
Close Asset Management 11k $28k 0% Sep 2024
 View chart
Wealth Enhancement Advisory Services 11k $29k 0% Jun 2024
 View chart
Mariner Wealth Advisors 11k $26k 0% Sep 2024
 View chart
Glass Jacobson Investment Advisors 11k $26k 0% Sep 2024
 View chart
Oxford Asset Management 10k $26k 100% Jun 2024
 View chart
Steward Partners Investment Advisory 8.8k $23k 0% Jun 2024
 View chart
Royal Bank of Canada 4.2k $10k -17% Sep 2024
 View chart
Advisor Group Holdings 3.8k $9.4k -17% Sep 2024
 View chart
Northwestern Mutual Wealth Management Company 1.6k $3.8k 0% Sep 2024
 View chart
City Holding 1.1k $2.6k 0% Sep 2024
 View chart
Proequities 1.0k $2.4M 0% Sep 2024
 View chart
Nordwand Advisors 1.0k $2.4k 100% Sep 2024
 View chart
Jones Financial Companies, L.L 572.00 $1.4k 100% Sep 2024
 View chart
IFP Advisors 500.00 $1.3k 0% Jun 2024
 View chart
Russell Investments 250.00 $643.000000 100% Jun 2024
 View chart
Beacon Capital Management 219.00 $534.009600 0% Sep 2024
 View chart
Qube Research & Technologies 107.00 $285.336900 -100% Jun 2024
 View chart
Group One Trading 100.00 $244.000000 -99% Sep 2024
 View chart
Huntington National Bank 2.00 $5.000000 -100% Sep 2024
 View chart

Who sold out of Oramed Pharm?

Fund or Company Name Date Sold Shares Held Valued At
D. E. Shaw & Co Jun 2024 39k $99k
Millennium Management Jun 2024 20k $50k
XTX Topco Jun 2024 16k $40k
Jpmorgan Chase & Co Jun 2024 6.9k $18k
Rhumbline Advisers Jun 2024 1.8k $4.7k
Compagnie Lombard, Odier SCA Jun 2024 875.00 $2.2k
Mather Group Jun 2024 100.00 $292.000000
Global Retirement Partners Jun 2024 100.00 $257.000000
Simplex Trading Jun 2024 75.00 $0
Innealta Capital Jun 2024 13.00 $33.000500